M. Rosandich

发表

Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells.

P. Ghezzi, C. Dinarello, C. White, 1991, Cytokine.

Emergence of Dual Resistance to Zidovudine and Lamivudine in Clinical HIV-1 Isolates from Patients Receiving Zidovudine/Lamivudine Combination Therapy

D. Kuritzkes, M. Rosandich, Rebekah JA Gass, 1998 .

Generation of superoxide anion by brain endothelial cell xanthine oxidase

J. Repine, J. Leff, L. Terada, 1991, Journal of cellular physiology.

Cytotoxic T lymphocyte lines specific for human immunodeficiency virus type 1 Gag and reverse transcriptase derived from a vertically infected child.

R. Schooley, D. Kuritzkes, T. Curiel, 1993, Journal of Infectious Diseases.

Ro/SSA antigen in human epidermis

S. Coulter, M. Rosandich, S. Jones, 1988, The British journal of dermatology.

Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 Investigators.

C. Pettinelli, I. Marschner, V. Johnson, 1999, AIDS.

Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells

R. Schooley, D. Kuritzkes, R. Pomerantz, 2000 .

Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS Clinical Trials Groups 209 and 214.

B. Walker, R. Schooley, M. Hirsch, 2000, The Journal of infectious diseases.

Phase 1 study of combination therapy with L-697,661 and zidovudine

R. Schooley, J. Phair, J. Kahn, 1996 .